Literature DB >> 21212395

Microinfarct pathology, dementia, and cognitive systems.

Zoe Arvanitakis1, Sue E Leurgans, Lisa L Barnes, David A Bennett, Julie A Schneider.   

Abstract

BACKGROUND AND
PURPOSE: Little is known about the role of microinfarcts in dementia and cognition. We examined microinfarcts and dementia, global cognition, and 5 cognitive systems in community-dwelling older persons.
METHODS: Four hundred twenty-five subjects enrolled in the Religious Orders Study underwent annual clinical evaluations, including 19 neuropsychological tests and assessment for dementia, and brain autopsy (39% men; mean age at death, 87; Mini-Mental State Examination score, 21). Neuropathologic examination documented the presence, number, and location of chronic microinfarcts on 6-μm hematoxylin-eosin-stained sections from cortical and subcortical regions. Multiple regression analyses adjusted for age at death, sex, education, macroscopic infarcts, Alzheimer disease pathology, and Lewy bodies.
RESULTS: Microinfarcts were present in 129 of 425 (30%) persons (54 cortical, 80 subcortical, 49 multiple); 58 of 129 (45%) of persons with microinfarcts did not exhibit macroscopic infarcts. Persons with microinfarcts had increased odds of dementia (OR, 1.77; 95% CI, 1.07-2.92), especially those persons with multiple cortical microinfarcts. Microinfarcts were also associated with lower average global cognition (estimate, -0.287; SE, 0.113; P=0.012), particularly for persons with multiple cortical microinfarcts. Microinfarcts were specifically associated with lower episodic memory (estimate, -0.279; SE, 0.138; P=0.044), semantic memory (estimate, -0.391; SE, 0.130; P=0.003), and perceptual speed (estimate, -0.400; SE, 0.117; P<0.001). In addition, single, multiple, and cortical microinfarcts were associated with worse semantic memory and perceptual speed (all P<0.028). Neither macroscopic infarcts nor AD pathology modified these associations (all P>0.154).
CONCLUSIONS: Microinfarcts are common, and persons with multiple cortical microinfarcts have higher odds of dementia. Microinfarcts are also associated with lower cognition, specifically perceptual speed and semantic and episodic memory.

Entities:  

Mesh:

Year:  2011        PMID: 21212395      PMCID: PMC3042494          DOI: 10.1161/STROKEAHA.110.595082

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  26 in total

1.  Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants.

Authors:  Lon White; Helen Petrovitch; John Hardman; James Nelson; Daron G Davis; G Webster Ross; Kamal Masaki; Lenore Launer; William R Markesbery
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

2.  Relation of cerebral infarctions to dementia and cognitive function in older persons.

Authors:  J A Schneider; R S Wilson; E J Cochran; J L Bienias; S E Arnold; D A Evans; D A Bennett
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

3.  Observations on the brains of demented old people.

Authors:  B E Tomlinson; G Blessed; M Roth
Journal:  J Neurol Sci       Date:  1970-09       Impact factor: 3.181

4.  The apolipoprotein E epsilon 2 allele and decline in episodic memory.

Authors:  R S Wilson; J L Bienias; E Berry-Kravis; D A Evans; D A Bennett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

5.  Which vascular lesions are of importance in vascular dementia?

Authors:  M M Esiri
Journal:  Ann N Y Acad Sci       Date:  2000-04       Impact factor: 5.691

Review 6.  Neuropathologic substrates of ischemic vascular dementia.

Authors:  H V Vinters; W G Ellis; C Zarow; B W Zaias; W J Jagust; W J Mack; H C Chui
Journal:  J Neuropathol Exp Neurol       Date:  2000-11       Impact factor: 3.685

7.  Natural history of mild cognitive impairment in older persons.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; L A Beckett; N T Aggarwal; L L Barnes; J H Fox; J Bach
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

8.  Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; N T Aggarwal; S E Arnold; E J Cochran; E Berry-Kravis; J L Bienias
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

9.  Cortical microinfarcts and demyelination significantly affect cognition in brain aging.

Authors:  Enikö Kövari; Gabriel Gold; François R Herrmann; Alessandra Canuto; Patrick R Hof; Jean-Pierre Michel; Constantin Bouras; Panteleimon Giannakopoulos
Journal:  Stroke       Date:  2004-01-05       Impact factor: 7.914

10.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06
View more
  168 in total

1.  Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Panagiotis Fotiadis; Sergi Martinez-Ramirez; David H Salat; Aaron Schultz; Ashkan Shoamanesh; Alison M Ayres; Anastasia Vashkevich; Diana Rosas; Kristin Schwab; Alexander Leemans; Geert-Jan Biessels; Jonathan Rosand; Keith A Johnson; Anand Viswanathan; M Edip Gurol; Steven M Greenberg
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

Review 2.  Cerebral microinfarcts: the invisible lesions.

Authors:  Eric E Smith; Julie A Schneider; Joanna M Wardlaw; Steven M Greenberg
Journal:  Lancet Neurol       Date:  2012-03       Impact factor: 44.182

Review 3.  Selected findings from the Religious Orders Study and Rush Memory and Aging Project.

Authors:  David A Bennett; Robert S Wilson; Zoe Arvanitakis; Patricia A Boyle; Leyla de Toledo-Morrell; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 4.  Clinical-pathologic correlations in vascular cognitive impairment and dementia.

Authors:  Margaret Flanagan; Eric B Larson; Caitlin S Latimer; Brenna Cholerton; Paul K Crane; Kathleen S Montine; Lon R White; C Dirk Keene; Thomas J Montine
Journal:  Biochim Biophys Acta       Date:  2015-08-28

5.  Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation.

Authors:  Jan W Schrickel; Markus Linhart; Dietmar Bänsch; Daniel Thomas; Georg Nickenig
Journal:  Clin Res Cardiol       Date:  2015-10-29       Impact factor: 5.460

6.  Aberrant white matter networks mediate cognitive impairment in patients with silent lacunar infarcts in basal ganglia territory.

Authors:  Jinfu Tang; Suyu Zhong; Yaojing Chen; Kewei Chen; Junying Zhang; Gaolang Gong; Adam S Fleisher; Yong He; Zhanjun Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-15       Impact factor: 6.200

7.  Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology.

Authors:  Ali Ezzati; Cuiling Wang; Richard B Lipton; Dorothea Altschul; Mindy J Katz; Dennis W Dickson; Carol A Derby
Journal:  J Am Geriatr Soc       Date:  2017-04-13       Impact factor: 5.562

8.  Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study.

Authors:  Zoe Arvanitakis; Robin L Brey; Jacob H Rand; Julie A Schneider; Sue E Leurgans; Lei Yu; Aron S Buchman; Konstantinos Arfanakis; Debra A Fleischman; Patricia A Boyle; David A Bennett; Steven R Levine
Journal:  Neuroepidemiology       Date:  2012-10-24       Impact factor: 3.282

9.  Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology.

Authors:  Jeremy J Pruzin; Julie A Schneider; Ana W Capuano; Sue E Leurgans; Lisa L Barnes; Rexford S Ahima; Steven E Arnold; David A Bennett; Zoe Arvanitakis
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jan-Mar       Impact factor: 2.703

10.  TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

Authors:  Bryan D James; Robert S Wilson; Patricia A Boyle; John Q Trojanowski; David A Bennett; Julie A Schneider
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.